Figs Announces Q3 Earnings Per Share of 5 Cents, Exceeding Consensus Estimate of 2 Cents
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Should l Buy FIGS?
Q3 Revenue Performance: FIGS reported a Q3 revenue of $151.7 million, surpassing the consensus estimate of $142.46 million.
CEO's Statement: Trina Spear, CEO and Co-Founder, highlighted that the results exceeded internal expectations and marked the strongest revenue growth in two years.
Business Momentum: The company attributes its success to a strong product assortment and impactful brand moments, which have driven momentum in scrubwear and the U.S. business.
Long-term Outlook: FIGS believes that their strategic actions will enhance the fundamental drivers of their healthy business in the long run, reinforcing their position as leaders in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIGS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIGS
Wall Street analysts forecast FIGS stock price to fall
5 Analyst Rating
2 Buy
2 Hold
1 Sell
Hold
Current: 14.850
Low
7.50
Averages
10.70
High
15.00
Current: 14.850
Low
7.50
Averages
10.70
High
15.00
About FIGS
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle brand. The Company sells products designed to serve the particular needs of healthcare professionals primarily through its direct-to-consumer (DTC) digital platform, consisting of its Website, mobile app and B2B business (TEAMS). Its offerings include scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. Its non-scrubwear products are designed as an integrated system that complements its scrubwear and are comprised of base layer and outer layer products. Its underscrubs include sports bras, performance leggings, performance tops and super-soft pima cotton tops. Its under underscrubs include several styles of underwear. Its outer layer products include footwear, lab coats, and a variety of vests, jackets, and fleeces. The Company also offers necessities, such as scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare is Human Act Aims to Address Workforce Shortages
- Legislative Background: The Healthcare is Human Act, sponsored by Representatives Claudia Tenney and Steven Horsford, aims to address workforce shortages and burnout in the healthcare sector by providing a federal tax credit of up to $6,000 per year, thereby enhancing service quality and attracting more professionals to the field.
- Industry Status: According to the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas nationwide, highlighting the urgency for medical services and the critical need for skilled professionals.
- Policy Impact: This legislation not only offers financial incentives to healthcare professionals working in shortage areas but also aims to reduce turnover by improving pay and working conditions, ensuring that communities receive the medical care they need.
- Corporate Support: FIGS CEO Trina Spear emphasized that this historic bill recognizes the contributions of healthcare professionals through tax credits, demonstrating a commitment to the healthcare sector and further promoting sustainable industry growth.
See More
Healthcare is Human Act Introduced to Support Healthcare Workers
- Legislative Background: The bipartisan Healthcare is Human Act, co-sponsored by Reps. Claudia Tenney and Steven Horsford, aims to provide a federal tax credit of up to $6,000 annually to healthcare professionals, directly addressing low pay and staffing shortages that contribute to burnout and turnover in the healthcare sector.
- Healthcare Shortage Reality: According to the latest report from the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas in the U.S., highlighting the urgent need for healthcare services, and the implementation of this legislation will help attract more professionals to these critical fields.
- Policy Impact: This act not only provides financial incentives for current healthcare workers but also aims to improve medical services in rural areas and those serving veterans, ensuring these communities receive timely care and ultimately enhancing overall public health outcomes.
- Industry Response: FIGS CEO Trina Spear stated that this legislation is historic, reflecting recognition and support for healthcare professionals, emphasizing the importance of the healthcare industry to society, and hopes to enhance the respect and value of healthcare workers through this initiative.
See More
Wall Street's Affection for FIGS: What Do Price Targets Indicate About a Potential Decline?
Stock Performance: Following a significant recovery, FIGS, Inc. has seen its stock surge nearly 260% over the past year, currently trading above $17, despite a consensus 12-month price target of $12.25, indicating skepticism about its valuation.
Earnings Momentum: The company reported strong earnings growth, with Q3 2025 results exceeding expectations, leading to a stock rally of over 30% and prompting analysts to upgrade their ratings, reflecting confidence in FIGS' future prospects.
Market Challenges: Despite positive earnings, analysts express caution regarding the stock's valuation, noting that it trades at a high price-to-earnings ratio, suggesting that much of the expected growth may already be priced in.
Future Outlook: FIGS anticipates continued revenue growth of 10% to 12% for fiscal 2026, driven by strong demand in the healthcare sector, while also planning to expand into new international markets and maintain its stock buyback program.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, reflecting varying market perspectives that could influence investor decisions and market trends.
- Investor Focus: Analysts' opinions are particularly crucial when considering the purchase of SMTC stock, as these insights may affect investor confidence and willingness to buy, directly impacting stock prices.
- Source of Updates: A complete view of all analyst rating changes, including upgrades and downgrades, can be found on our analyst ratings page, providing a comprehensive perspective to help investors make informed decisions.
- Market Dynamics Impact: The adjustments in analysts' ratings not only reflect views on company fundamentals but may also influence overall market sentiment, subsequently affecting trading volumes and price fluctuations of related stocks.
See More
Figs Shares Surge 23.9% Following Strong Quarterly Performance
- Quarterly Revenue Surge: Figs reported a 33% year-over-year increase in fourth-quarter revenue, reaching $201.9 million, highlighting strong demand in the healthcare apparel market and solidifying its market position.
- Sales Breakdown Performance: Scrubwear sales jumped 35.1% to $154.9 million, while non-scrubwear sales rose 26.4% to $47 million, indicating the success of the company's diversified product strategy.
- International Market Expansion: Figs' international revenue soared 55.1% to $37.7 million, reflecting the effectiveness of its global expansion strategy, which is expected to drive future growth.
- Optimistic Future Outlook: Figs anticipates full-year revenue growth of 10% to 12% for 2026 and plans to increase its adjusted EBITDA margin from 11.8% in 2025 to 12.8%, demonstrating confidence in its future performance.
See More
Figs Reports Strong Sales Growth, Shares Rise 23%
- Significant Sales Growth: Figs' fourth-quarter revenue surged 33% year-over-year to $201.9 million, with Scrubwear sales jumping 35.1% to $154.9 million and non-scrubwear sales increasing 26.4% to $47 million, indicating strong demand in the healthcare apparel market.
- Strong Regional Performance: U.S. revenue rose 28.7% to $164.2 million, while international revenue soared 55.1% to $37.7 million, demonstrating Figs' rapidly increasing market penetration among healthcare professionals globally.
- Improved Profitability: Figs' EBITDA climbed 26.8% to $26.7 million, with projections for an adjusted EBITDA margin of 12.8% in 2026, up from 11.8% in 2025, reflecting ongoing enhancements in the company's profitability.
- Optimistic Investment Outlook: Analysts at KeyBanc set a $17 price target for Figs' shares, indicating a potential 10% return from Friday's closing price, showcasing market confidence in the company's future growth prospects.
See More
Healthcare is Human Act Aims to Address Workforce Shortages
- Legislative Background: The Healthcare is Human Act, sponsored by Representatives Claudia Tenney and Steven Horsford, aims to address workforce shortages and burnout in the healthcare sector by providing a federal tax credit of up to $6,000 per year, thereby enhancing service quality and attracting more professionals to the field.
- Industry Status: According to the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas nationwide, highlighting the urgency for medical services and the critical need for skilled professionals.
- Policy Impact: This legislation not only offers financial incentives to healthcare professionals working in shortage areas but also aims to reduce turnover by improving pay and working conditions, ensuring that communities receive the medical care they need.
- Corporate Support: FIGS CEO Trina Spear emphasized that this historic bill recognizes the contributions of healthcare professionals through tax credits, demonstrating a commitment to the healthcare sector and further promoting sustainable industry growth.
See More
Healthcare is Human Act Introduced to Support Healthcare Workers
- Legislative Background: The bipartisan Healthcare is Human Act, co-sponsored by Reps. Claudia Tenney and Steven Horsford, aims to provide a federal tax credit of up to $6,000 annually to healthcare professionals, directly addressing low pay and staffing shortages that contribute to burnout and turnover in the healthcare sector.
- Healthcare Shortage Reality: According to the latest report from the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas in the U.S., highlighting the urgent need for healthcare services, and the implementation of this legislation will help attract more professionals to these critical fields.
- Policy Impact: This act not only provides financial incentives for current healthcare workers but also aims to improve medical services in rural areas and those serving veterans, ensuring these communities receive timely care and ultimately enhancing overall public health outcomes.
- Industry Response: FIGS CEO Trina Spear stated that this legislation is historic, reflecting recognition and support for healthcare professionals, emphasizing the importance of the healthcare industry to society, and hopes to enhance the respect and value of healthcare workers through this initiative.
See More
Wall Street's Affection for FIGS: What Do Price Targets Indicate About a Potential Decline?
Stock Performance: Following a significant recovery, FIGS, Inc. has seen its stock surge nearly 260% over the past year, currently trading above $17, despite a consensus 12-month price target of $12.25, indicating skepticism about its valuation.
Earnings Momentum: The company reported strong earnings growth, with Q3 2025 results exceeding expectations, leading to a stock rally of over 30% and prompting analysts to upgrade their ratings, reflecting confidence in FIGS' future prospects.
Market Challenges: Despite positive earnings, analysts express caution regarding the stock's valuation, noting that it trades at a high price-to-earnings ratio, suggesting that much of the expected growth may already be priced in.
Future Outlook: FIGS anticipates continued revenue growth of 10% to 12% for fiscal 2026, driven by strong demand in the healthcare sector, while also planning to expand into new international markets and maintain its stock buyback program.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, reflecting varying market perspectives that could influence investor decisions and market trends.
- Investor Focus: Analysts' opinions are particularly crucial when considering the purchase of SMTC stock, as these insights may affect investor confidence and willingness to buy, directly impacting stock prices.
- Source of Updates: A complete view of all analyst rating changes, including upgrades and downgrades, can be found on our analyst ratings page, providing a comprehensive perspective to help investors make informed decisions.
- Market Dynamics Impact: The adjustments in analysts' ratings not only reflect views on company fundamentals but may also influence overall market sentiment, subsequently affecting trading volumes and price fluctuations of related stocks.
See More
Figs Shares Surge 23.9% Following Strong Quarterly Performance
- Quarterly Revenue Surge: Figs reported a 33% year-over-year increase in fourth-quarter revenue, reaching $201.9 million, highlighting strong demand in the healthcare apparel market and solidifying its market position.
- Sales Breakdown Performance: Scrubwear sales jumped 35.1% to $154.9 million, while non-scrubwear sales rose 26.4% to $47 million, indicating the success of the company's diversified product strategy.
- International Market Expansion: Figs' international revenue soared 55.1% to $37.7 million, reflecting the effectiveness of its global expansion strategy, which is expected to drive future growth.
- Optimistic Future Outlook: Figs anticipates full-year revenue growth of 10% to 12% for 2026 and plans to increase its adjusted EBITDA margin from 11.8% in 2025 to 12.8%, demonstrating confidence in its future performance.
See More
Figs Reports Strong Sales Growth, Shares Rise 23%
- Significant Sales Growth: Figs' fourth-quarter revenue surged 33% year-over-year to $201.9 million, with Scrubwear sales jumping 35.1% to $154.9 million and non-scrubwear sales increasing 26.4% to $47 million, indicating strong demand in the healthcare apparel market.
- Strong Regional Performance: U.S. revenue rose 28.7% to $164.2 million, while international revenue soared 55.1% to $37.7 million, demonstrating Figs' rapidly increasing market penetration among healthcare professionals globally.
- Improved Profitability: Figs' EBITDA climbed 26.8% to $26.7 million, with projections for an adjusted EBITDA margin of 12.8% in 2026, up from 11.8% in 2025, reflecting ongoing enhancements in the company's profitability.
- Optimistic Investment Outlook: Analysts at KeyBanc set a $17 price target for Figs' shares, indicating a potential 10% return from Friday's closing price, showcasing market confidence in the company's future growth prospects.
See More
